Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 94,606 |
|
|||||
| News | - | ||||||
| Day High | 2.17 | Low High |
|||||
| Day Low | 1.95 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Acurx Pharmaceuticals Inc | ACXP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.20 | -9.39% | 1.93 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.08 | 1.95 | 2.17 | 2.01 | 2.13 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 427 | 94,606 | US$ 2.07 | US$ 195,622 | - | 1.17 - 8.82 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:49:51 | formt | 695 | US$ 1.93 | USD |
Acurx Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.09M | 13.77M | - | 0 | -14.58M | -1.06 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acurx Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACXP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.86 | 2.17 | 1.52 | 1.79 | 154,964 | 0.07 | 3.76% |
| 1 Month | 2.00 | 2.48 | 1.52 | 1.94 | 92,083 | -0.07 | -3.50% |
| 3 Months | 4.00 | 4.00 | 1.52 | 2.68 | 103,754 | -2.07 | -51.75% |
| 6 Months | 5.72 | 5.9688 | 1.52 | 3.81 | 233,415 | -3.79 | -66.26% |
| 1 Year | 3.11 | 8.82 | 1.17 | 3.41 | 273,553 | -1.18 | -37.94% |
| 3 Years | 5.95 | 8.82 | 1.17 | 4.37 | 158,874 | -4.02 | -67.56% |
| 5 Years | 5.95 | 8.82 | 1.17 | 4.37 | 158,874 | -4.02 | -67.56% |
Acurx Pharmaceuticals Description
| Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. |
